Bio-Rad Laboratories (BIO) Change in Receivables (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Change in Receivables of $614.1 million for Q1 2026, down 4.05% year-over-year from $640.0 million in Q1 2025, and down 11.98% quarter-over-quarter from $697.7 million in Q4 2025.
Bio-Rad Laboratories (BIO) Change in Receivables (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Change in Receivables for 18 consecutive years, with $614.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables fell 4.05% year-over-year to $614.1 million; the TTM figure through Mar 2026 stood at $2.6 billion (up 2.96% YoY), while the FY2025 annual figure was $2.7 billion, up 4.05% from the prior year.
- Change in Receivables eased to $614.1 million in Q1 2026 per BIO's latest filing, from $697.7 million in the prior quarter.
- Across five years, Change in Receivables topped out at $717.4 million in Q4 2022 and bottomed at $614.1 million in Q1 2026.
- Historically, Change in Receivables has averaged $659.2 million across 5 years, with a median of $655.5 million in 2024.
- Annual changes were most pronounced in 2022 — Change in Receivables dropped 10.72% — and 2025, when it grew 10.38%.
- Bio-Rad Laboratories' Change in Receivables stood at $717.4 million in 2022, then fell by 5.68% to $676.7 million in 2023, then decreased by 6.59% to $632.1 million in 2024, then rose by 10.38% to $697.7 million in 2025, then dropped by 11.98% to $614.1 million in 2026.
- Business Quant data shows BIO's Change in Receivables at $614.1 million in Q1 2026, $697.7 million in Q4 2025, and $653.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Bio-Rad Laboratories | 10.08 Bn | 8.46 Bn | 345.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 628.60 Mn |
| Jun 30, 2026 | 628.60 Mn |
| Mar 31, 2026 | 614.10 Mn |
| Mar 31, 2026 | 614.10 Mn |
| Dec 31, 2025 | 697.70 Mn |
| Dec 31, 2025 | 697.70 Mn |
| Sep 30, 2025 | 653.80 Mn |
| Sep 30, 2025 | 653.80 Mn |
| Jun 30, 2025 | 664.90 Mn |
| Jun 30, 2025 | 664.90 Mn |
| Mar 31, 2025 | 640.00 Mn |
| Mar 31, 2025 | 640.00 Mn |
| Dec 31, 2024 | 632.10 Mn |
| Dec 31, 2024 | 632.10 Mn |
| Sep 30, 2024 | 655.50 Mn |
| Sep 30, 2024 | 655.50 Mn |
| Jun 30, 2024 | 627.20 Mn |
| Jun 30, 2024 | 627.20 Mn |
| Mar 31, 2024 | 638.30 Mn |
| Mar 31, 2024 | 638.30 Mn |